Increasing Treatment for Obesity Among Underserved Populations
1 other identifier
interventional
200
1 country
1
Brief Summary
The objective of this project is to evaluate strategies to increase patient engagement in evidence-based interventions (EBIs) for obesity. The scientific premise of the proposed project is based on: 1) substantial evidence that EBIs for obesity are effective but grossly underutilized, 2) promising results indicating that technology-based approaches such as text messaging may increase the reach of EBIs among underserved populations, 3) data demonstrating that repeated offers of treatment can substantially increase enrollment even among patients who are initially unmotivated, and 4) prior research highlighting the effectiveness of Motivation And Problem Solving (MAPS), a proactive coaching approach used to address barriers to improve patient enrollment in EBIs. Thus, the proposed project will develop, implement, and evaluate two strategies for increasing the assessment and enrollment of University of Utah Medicaid patients in online EBIs for obesity: 1) Repeated offers of EBIs for obesity using text messaging and state of the science health communication strategies, 2) MAPS navigation/counseling among patients who do not enroll in EBIs in response to text messaging. The proposed project will provide critical data regarding the implementation of pragmatic and scalable interventions that are designed to increase the reach of existing EBIs for obesity among underserved populations. Most importantly, the project results lay the foundation for the widespread dissemination of strategies to increase use of EBIs for obesity across Utah, the Mountain West region, and the nation. Project deliverables include 1) a text messaging intervention for facilitating connection to EBIs for obesity; 2) MAPS intervention for facilitating connection to EBIs for obesity; 3) implementation, adaptation, and optimization of these interventions for University of Utah Medicaid patients, 4) preliminary evidence for the efficacy of these two interventions in improving the reach of EBIs for obesity, and 5) creation of a plan for further dissemination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Mar 2022
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 23, 2022
CompletedFirst Submitted
Initial submission to the registry
December 16, 2022
CompletedFirst Posted
Study publicly available on registry
December 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 8, 2023
CompletedMay 31, 2024
May 1, 2024
11 months
December 16, 2022
May 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of participants who were eligible, contacted, and enrolled in the trial.
Proportion of participants who were eligible, contacted, and enrolled in the trial.
at 12 weeks
Secondary Outcomes (4)
Evidence-Based Intervention REACH Phase 1
at 12 weeks
Evidence-Based Intervention REACH Phase 2
at 24 weeks
Participant engagement with dissemination strategies
at 24 weeks
Evidence-Based Intervention Engagement
at 12 weeks from enrollment
Study Arms (6)
Phase 1: TM1
EXPERIMENTALPatients in the TM1 condition will be randomized to receive either an autonomy supportive message, or a directive motivational message.
Phase 1: TM+
EXPERIMENTALPatients in the TM+ condition will be randomized to receive 5 text messages in scheduled succession. These messages will be either an autonomy supportive message, or a directive motivational message.
Phase 2: TM1 and PN
EXPERIMENTALPatients in the TM1 and PN condition will be randomized to receive either an autonomy supportive message, or a directive motivational message. Additionally, they will receive the option to talk with a Patient Navigator to receive MAPS coaching
Phase 2: TM1 continued
EXPERIMENTALPatients in the TM1 continued arm have the continued option to reply to the first text message in "Phase 1: TM1." They do not receive any additional intervention.
Phase 2: TM+ and PN
EXPERIMENTALPatients in the TM+ and PN condition will be randomized to receive 3 additional either autonomy supportive messages, or directive motivational messages. Additionally, they will receive the option to talk with a Patient Navigator to receive MAPS coaching
Phase 2: TM+ continued
EXPERIMENTALPatients in TM+ continued will receive 3 additional either autonomy supportive messages, or directive motivational messages.
Interventions
Receives single text message
Receive phone calls from trained MAPS counselors
Receives multiple scheduled text messages
Eligibility Criteria
You may qualify if:
- Participants will be adults aged 18+
- have a BMI of 30 or higher
- have had a primary care appointment within University of Utah Health within the past year
- speak English or Spanish as their primary language
- have a current Utah address
- are insured through Medicaid (University of Utah Health Plans).
You may not qualify if:
- patients may not have a diagnosis of Type 1 or Type 2 Diabetes
- being currently pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Huntsman Cancer Institute/University of Utah
Salt Lake City, Utah, 84112, United States
Related Publications (1)
Schlechter CR, Del Fiol G, Jones DR, Orleans B, Gibson B, Nahum-Shani I, Maxfield E, Locke A, Cornia R, Bradshaw R, Wirth J, Jaggers SJ, Lam CY, Wetter DW. Increasing the reach of evidence-based interventions for weight management and diabetes prevention among Medicaid patients: study protocol for a pilot Sequential Multiple Assignment Randomised Trial. BMJ Open. 2023 Nov 27;13(11):e075157. doi: 10.1136/bmjopen-2023-075157.
PMID: 38011967DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Wetter, PhD
University of Utah
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
December 16, 2022
First Posted
December 27, 2022
Study Start
March 23, 2022
Primary Completion
February 8, 2023
Study Completion
February 8, 2023
Last Updated
May 31, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share